Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.075 USD | -2.04% | -9.33% | +53.96% |
May. 08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.96% | 235M | |
+63.36% | 62.59B | |
-2.09% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.38% | 26.21B | |
-22.05% | 19.09B | |
+3.53% | 13.08B | |
+25.50% | 12.26B | |
+27.07% | 12.05B |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- Wedbush Downgrades Design Therapeutics to Neutral From Outperform, Pushes Back DT-216 Launch Timing; Cuts PT to $6 From $19